What is PSA-PF's earnings per share (EPS)?

PSA-PF (PSA-PF) reported diluted earnings per share of $9.01 for fiscal year 2025. This represents a -15.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

PSA-PF Financials

PSA-PF

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows PSA-PF (PSA-PF) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 19 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI PSA-PF FY2025 2026-04-22

Cash flow stays steadier than earnings as an increasingly debt-funded asset base absorbs more interest and depreciation.

Across recent years, operating cash flow stayed close to $3.2B even as net income slipped to $1.78B. At the same time, depreciation rose above $1.15B and interest expense reached $304M, so reported earnings carry more non-cash and financing drag than cash generation does.

Long-term debt climbed to $10.25B as cash fell to $318M. Because revenue reached only $4.82B, the balance sheet is carrying a financing load that is large relative to the business's annual top line, leaving less flexibility if funding costs rise.

Selling and administrative expense was about $107M, versus depreciation of $1.15B. That gap shows the cost structure is driven far more by owning and aging the asset base than by overhead, so cash conversion depends more on asset economics and financing terms than on simply adding people costs.

Financial Health Signals

Financial Profile 29/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of PSA-PF's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth

PSA-PF's revenue grew a modest 2.7% year-over-year to $4.8B. This slow but positive growth earns a score of 39/100.

Leverage

PSA-PF carries a low D/E ratio of 1.11, meaning only $1.11 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 79/100, indicating a strong balance sheet with room for future borrowing.

Returns

PSA-PF's ROE of 19.3% shows moderate profitability relative to equity, earning a score of 56/100. This is down from 21.3% the prior year.

Piotroski F-Score Neutral

4/9

PSA-PF passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Cash-Backed

1.79x

For every $1 of reported earnings, PSA-PF generates $1.79 in operating cash flow ($3.2B OCF vs $1.8B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$4.8B

YoY+2.7%

5Y CAGR+10.6%

10Y CAGR+7.3%

PSA-PF generated $4.8B in revenue in fiscal year 2025. This represents an increase of 2.7% from the prior year.

EBITDA

N/A

Net Income

$1.8B

YoY-13.9%

5Y CAGR+5.6%

10Y CAGR+3.1%

PSA-PF reported $1.8B in net income in fiscal year 2025. This represents a decrease of 13.9% from the prior year.

EPS (Diluted)

$9.01

YoY-15.3%

5Y CAGR+7.5%

10Y CAGR+4.0%

PSA-PF earned $9.01 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 15.3% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$318.1M

YoY-28.9%

5Y CAGR+4.3%

10Y CAGR+11.8%

PSA-PF held $318.1M in cash against $10.3B in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

176M

5Y CAGR+0.1%

10Y CAGR+0.1%

PSA-PF had 176M shares outstanding in fiscal year 2025.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

37.0%

YoY-7.1pp

5Y CAGR-9.6pp

10Y CAGR-18.1pp

PSA-PF's net profit margin was 37.0% in fiscal year 2025, showing the share of revenue converted to profit. This is down 7.1 percentage points from the prior year.

Return on Equity

19.3%

YoY-2.0pp

5Y CAGR+3.4pp

10Y CAGR+5.0pp

PSA-PF's ROE was 19.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 2.0 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

YoY-100.0%

PSA-PF spent $0 on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 100.0% from the prior year.

Capital Expenditures

N/A

PSA-PF Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$4.8B+2.7%	$4.7B+3.9%	$4.5B+8.0%	$4.2B+22.4%	$3.4B+17.2%	$2.9B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$106.7M0.0%	$106.7M+32.3%	$80.6M+12.5%	$71.7M-5.7%	$76.0M-8.7%	$83.2M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$304.5M+5.9%	$287.4M+42.9%	$201.1M+47.5%	$136.3M+50.2%	$90.8M+61.3%	$56.3M
Income Tax	-$7.2M-254.8%	$4.7M-56.9%	$10.8M-24.5%	$14.3M+15.9%	$12.4M	N/A
Net Income	$1.8B-13.9%	$2.1B-3.6%	$2.1B-50.6%	$4.3B+122.7%	$2.0B+43.9%	$1.4B
EPS (Diluted)	$9.01-15.3%	$10.64-3.8%	$11.06-52.9%	$23.50+138.1%	$9.87+56.9%	$6.29

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$1.2B+0.2%	$1.2B-0.7%	$1.2B+1.9%	$1.2B+1.5%	$1.2B+0.5%	$1.2B-0.9%	$1.2B+1.2%	$1.2B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$30.4M+12.5%	$27.0M-6.2%	$28.8M+11.9%	$25.7M+2.2%	$25.2M-22.6%	$32.5M+24.2%	$26.2M-1.4%	$26.6M
Operating Income	$474.3M	N/A	N/A	N/A	$464.0M	N/A	N/A	N/A
Interest Expense	$80.0M-1.4%	$81.2M+1.9%	$79.7M+11.3%	$71.6M-0.6%	$72.0M-0.2%	$72.1M-2.9%	$74.3M+1.4%	$73.2M
Income Tax	$1.6M+110.7%	-$14.7M-620.1%	$2.8M-12.6%	$3.2M+127.2%	$1.4M+203.9%	-$1.4M-155.2%	$2.5M+19.9%	$2.1M
Net Income	$526.3M+3.8%	$507.1M-0.8%	$511.1M+42.6%	$358.4M-12.1%	$407.8M-33.7%	$614.6M+42.8%	$430.3M-16.9%	$518.1M
EPS (Diluted)	$2.71	N/A	$2.62+48.9%	$1.76-13.7%	$2.04	N/A	$2.16-18.8%	$2.66

PSA-PF Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$20.2B+2.3%	$19.8B-0.3%	$19.8B+12.9%	$17.6B+1.0%	$17.4B+47.1%	$11.8B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$318.1M-28.9%	$447.4M+20.9%	$370.0M-52.3%	$775.3M+5.5%	$734.6M+185.2%	$257.6M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$165.8M0.0%	$165.8M0.0%	$165.8M0.0%	$165.8M0.0%	$165.8M0.0%	$165.8M
Total Liabilities	$10.9B+9.3%	$9.9B+2.5%	$9.7B+31.4%	$7.4B-7.2%	$8.0B+145.6%	$3.2B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$10.3B+9.6%	$9.4B+2.7%	$9.1B+32.5%	$6.9B-8.1%	$7.5B+193.7%	$2.5B
Total Equity	$9.2B-4.8%	$9.7B-3.0%	$10.0B-0.6%	$10.1B+7.9%	$9.3B+9.1%	$8.6B
Retained Earnings	-$1.2B-74.4%	-$699.1M-160.9%	-$267.9M-143.0%	-$110.2M+80.0%	-$550.4M+39.8%	-$914.8M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$19.9B-1.8%	$20.2B+0.5%	$20.1B-2.1%	$20.5B+4.7%	$19.6B-0.7%	$19.8B-0.2%	$19.8B+0.1%	$19.8B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$134.6M-57.7%	$318.1M+7.3%	$296.5M-73.2%	$1.1B+284.6%	$287.2M-35.8%	$447.4M-25.3%	$599.0M+10.5%	$542.3M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$165.8M0.0%	$165.8M0.0%	$165.8M0.0%	$165.8M0.0%	$165.8M0.0%	$165.8M0.0%	$165.8M0.0%	$165.8M
Total Liabilities	$10.5B-3.1%	$10.9B+1.5%	$10.7B-3.2%	$11.1B+11.3%	$9.9B0.0%	$9.9B-1.5%	$10.1B+1.1%	$10.0B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$9.7B-5.3%	$10.3B+2.1%	$10.0B-3.8%	$10.4B+10.8%	$9.4B+0.8%	$9.4B-1.3%	$9.5B+0.8%	$9.4B
Total Equity	$9.2B-0.3%	$9.2B-0.7%	$9.3B-0.6%	$9.4B-2.0%	$9.6B-1.5%	$9.7B+1.1%	$9.6B-1.0%	$9.7B
Retained Earnings	-$1.3B-4.1%	-$1.2B-6.0%	-$1.2B-6.0%	-$1.1B-25.1%	-$867.4M-24.1%	-$699.1M+5.2%	-$737.5M-24.4%	-$592.7M

PSA-PF Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$3.2B+1.9%	$3.1B-3.6%	$3.2B+4.2%	$3.1B+22.6%	$2.5B+24.5%	$2.0B
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$1.7B-68.1%	-$1.0B+71.7%	-$3.5B-415.9%	$1.1B+120.1%	-$5.6B-397.8%	-$1.1B
Financing Cash Flow	-$1.6B+21.5%	-$2.1B-1740.6%	-$112.9M+97.3%	-$4.2B-219.9%	$3.5B+425.2%	-$1.1B
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$0-100.0%	$200.0M	$0	$0	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	$694.8M-5.3%	$733.6M-16.2%	$875.1M+0.3%	$872.7M+23.8%	$705.1M-8.3%	$768.6M-3.8%	$798.8M-10.8%	$895.3M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$147.3M+59.6%	-$364.3M+47.7%	-$696.0M-105.7%	-$338.3M-18.1%	-$286.5M+30.4%	-$411.6M-93.0%	-$213.3M-11.6%	-$191.1M
Financing Cash Flow	-$731.0M-110.3%	-$347.6M+64.8%	-$987.3M-448.9%	$283.0M+148.9%	-$578.8M-13.8%	-$508.6M+9.2%	-$559.9M-29.3%	-$432.9M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	$0	$0	N/A	N/A	$0	$0	N/A

PSA-PF Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	37.0%-7.1pp	44.1%-3.4pp	47.5%-56.4pp	104.0%+46.8pp	57.2%+10.6pp	46.6%
Return on Equity	19.3%-2.0pp	21.3%-0.1pp	21.4%-21.7pp	43.2%+22.2pp	20.9%+5.1pp	15.9%
Return on Assets	8.8%-1.7pp	10.5%-0.4pp	10.8%-13.9pp	24.8%+13.5pp	11.2%-0.3pp	11.5%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	1.11+0.1	0.96+0.1	0.91+0.2	0.68-0.1	0.80+0.5	0.30
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	39.0%	N/A	N/A	N/A	39.2%	N/A	N/A	N/A
Net Margin	43.2%+1.5pp	41.7%-0.0pp	41.8%+11.9pp	29.8%-4.6pp	34.5%-17.7pp	52.2%+16.0pp	36.2%-7.9pp	44.2%
Return on Equity	5.7%+0.2pp	5.5%0.0pp	5.5%+1.7pp	3.8%-0.4pp	4.3%-2.1pp	6.3%+1.8pp	4.5%-0.9pp	5.3%
Return on Assets	2.6%+0.1pp	2.5%-0.0pp	2.5%+0.8pp	1.7%-0.3pp	2.1%-1.0pp	3.1%+0.9pp	2.2%-0.5pp	2.6%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	1.05-0.1	1.11+0.0	1.08-0.0	1.11+0.1	0.99+0.0	0.96-0.0	0.99+0.0	0.97
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Frequently Asked Questions

What is PSA-PF's annual revenue?

PSA-PF (PSA-PF) reported $4.8B in total revenue for fiscal year 2025. This represents a 2.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is PSA-PF's revenue growing?

PSA-PF (PSA-PF) revenue grew by 2.7% year-over-year, from $4.7B to $4.8B in fiscal year 2025.

Is PSA-PF profitable?

Yes, PSA-PF (PSA-PF) reported a net income of $1.8B in fiscal year 2025, with a net profit margin of 37.0%.

How much debt does PSA-PF have?

As of fiscal year 2025, PSA-PF (PSA-PF) had $318.1M in cash and equivalents against $10.3B in long-term debt.

What is PSA-PF's net profit margin?

PSA-PF (PSA-PF) had a net profit margin of 37.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is PSA-PF's return on equity (ROE)?

PSA-PF (PSA-PF) has a return on equity of 19.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is PSA-PF's operating cash flow?

PSA-PF (PSA-PF) generated $3.2B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are PSA-PF's total assets?

PSA-PF (PSA-PF) had $20.2B in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does PSA-PF have outstanding?

PSA-PF (PSA-PF) had 176M shares outstanding as of fiscal year 2025.

What is PSA-PF's debt-to-equity ratio?

PSA-PF (PSA-PF) had a debt-to-equity ratio of 1.11 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is PSA-PF's return on assets (ROA)?

PSA-PF (PSA-PF) had a return on assets of 8.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is PSA-PF's Piotroski F-Score?

PSA-PF (PSA-PF) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are PSA-PF's earnings high quality?

PSA-PF (PSA-PF) has an earnings quality ratio of 1.79x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is PSA-PF?

PSA-PF (PSA-PF) scores 29 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.